Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Mutation Research
|
September 6, 2001
Genetic susceptibility and environmental estrogen-like compounds
V N Kristensen, E H Kure, B Erikstein, et al.
Pharmacogenetics
|
March 25, 1998
A rare CYP19 (aromatase) variant may increase the risk of breast cancer
V N Kristensen, T I Andersen, A Lindblom, et al.
The Pharmacogenomics Journal
|
March 18, 2015
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate
S Jabeen, L Holmboe, G I G Alnæs, et al.
Oncogene
|
March 14, 2000
Genetic variants of CYP19 (aromatase) and breast cancer risk
V N Kristensen, N Harada, N Yoshimura, et al.
Breast Cancer Research : BCR
|
April 18, 2001
Low frequency of E-cadherin alterations in familial breast cancer
S Salahshor, L Haixin, H Huo, et al.
The Pharmacogenomics Journal
|
February 17, 2010
SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance
H Edvardsen, P F Brunsvig, H Solvang, et al.
BMC Genomics
|
August 12, 2008
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
L O Baumbusch, J Aarøe, F E Johansen, et al.
Oncogene
|
August 18, 2009
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
S-K Leivonen, R Mäkelä, P Ostling, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Mutation Research
|
September 6, 2001
Genetic susceptibility and environmental estrogen-like compounds
V N Kristensen, E H Kure, B Erikstein, et al.
Pharmacogenetics
|
March 25, 1998
A rare CYP19 (aromatase) variant may increase the risk of breast cancer
V N Kristensen, T I Andersen, A Lindblom, et al.
The Pharmacogenomics Journal
|
March 18, 2015
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate
S Jabeen, L Holmboe, G I G Alnæs, et al.
Oncogene
|
March 14, 2000
Genetic variants of CYP19 (aromatase) and breast cancer risk
V N Kristensen, N Harada, N Yoshimura, et al.
Breast Cancer Research : BCR
|
April 18, 2001
Low frequency of E-cadherin alterations in familial breast cancer
S Salahshor, L Haixin, H Huo, et al.
The Pharmacogenomics Journal
|
February 17, 2010
SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance
H Edvardsen, P F Brunsvig, H Solvang, et al.
BMC Genomics
|
August 12, 2008
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
L O Baumbusch, J Aarøe, F E Johansen, et al.
Oncogene
|
August 18, 2009
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
S-K Leivonen, R Mäkelä, P Ostling, et al.
Page
of 2